Dongwei Kang

4.8k total citations
151 papers, 3.7k citations indexed

About

Dongwei Kang is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Dongwei Kang has authored 151 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 114 papers in Infectious Diseases, 93 papers in Virology and 58 papers in Epidemiology. Recurrent topics in Dongwei Kang's work include HIV/AIDS drug development and treatment (104 papers), HIV Research and Treatment (92 papers) and Pneumocystis jirovecii pneumonia detection and treatment (46 papers). Dongwei Kang is often cited by papers focused on HIV/AIDS drug development and treatment (104 papers), HIV Research and Treatment (92 papers) and Pneumocystis jirovecii pneumonia detection and treatment (46 papers). Dongwei Kang collaborates with scholars based in China, Belgium and United States. Dongwei Kang's co-authors include Xinyong Liu, Peng Zhan, Christophe Pannecouque, Erik De Clercq, Gaochan Wu, Boshi Huang, Xiangyi Jiang, Lanlan Jing, Zhongxia Zhou and Dirk Daelemans and has published in prestigious journals such as Journal of the American Chemical Society, Chemical Society Reviews and Angewandte Chemie International Edition.

In The Last Decade

Dongwei Kang

140 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dongwei Kang China	34	1.8k	1.4k	1.2k	1.2k	953	151	3.7k
Chris Meier Germany	32	1.6k 0.9×	1.5k 1.1×	2.1k 1.7×	647 0.5×	840 0.9×	224	3.8k
Peng Zhan China	46	3.7k 2.0×	3.2k 2.3×	2.5k 2.1×	2.4k 1.9×	1.8k 1.9×	297	7.9k
Choung U. Kim United States	28	889 0.5×	1.1k 0.8×	1.5k 1.2×	326 0.3×	1.6k 1.7×	59	3.3k
Anthony Wood United Kingdom	20	657 0.4×	1.5k 1.1×	993 0.8×	805 0.7×	184 0.2×	41	3.2k
Boshi Huang China	23	724 0.4×	669 0.5×	624 0.5×	570 0.5×	396 0.4×	69	1.7k
Bertil Samuelsson Sweden	34	843 0.5×	1.6k 1.2×	1.6k 1.3×	295 0.2×	351 0.4×	134	3.6k
Kent D. Stewart United States	34	559 0.3×	967 0.7×	1.3k 1.0×	322 0.3×	518 0.5×	91	3.1k
Vincenzo Summa Italy	25	764 0.4×	684 0.5×	857 0.7×	301 0.2×	346 0.4×	104	2.2k
W. Gary Tarpley United States	28	1.5k 0.8×	622 0.5×	1.2k 0.9×	1.5k 1.2×	289 0.3×	57	2.9k
Franck Amblard United States	22	878 0.5×	1.4k 1.0×	1.2k 1.0×	198 0.2×	524 0.5×	87	3.0k

Countries citing papers authored by Dongwei Kang

Since Specialization

Citations

This map shows the geographic impact of Dongwei Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongwei Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongwei Kang more than expected).

Fields of papers citing papers by Dongwei Kang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongwei Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongwei Kang. The network helps show where Dongwei Kang may publish in the future.

Co-authorship network of co-authors of Dongwei Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Dongwei Kang. A scholar is included among the top collaborators of Dongwei Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongwei Kang. Dongwei Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jiang, Xiangyi, Heng Gao, Zhen Gao, et al.. (2025). Structure- and Privileged Fragment-Based Iterative Optimization: Discovery of 2,4-Disubstituted-6-aminopyrimidines as Novel HIV-1 NNRTIs with Potent Activity against Drug-Resistant Strains and Favorable Safety Profiles. Journal of Medicinal Chemistry. 68(21). 23345–23362.

Sun, Yanying, Yanyang Qin, Na Wang, et al.. (2024). Discovery of 2,4,6-trisubstituted pyrimidine derivatives as novel potent HIV-1 NNRTIs by exploiting the tolerant region II of the NNIBP. European Journal of Medicinal Chemistry. 277. 116708–116708. 3 indexed citations

Jing, Lanlan, Gaochan Wu, Fabao Zhao, et al.. (2024). Discovery of potent HIV-1 NNRTIs by CuAAC click-chemistry-based miniaturized synthesis, rapid screening and structure optimization. European Journal of Medicinal Chemistry. 277. 116772–116772. 4 indexed citations

Wang, Zhao, Erik De Clercq, Christophe Pannecouque, et al.. (2024). Design and synthesis of Fsp³‐enriched spirocyclic‐substituted diarylpyrimidine derivatives as novel HIV‐1 NNRTIs. Chemical Biology & Drug Design. 103(3). e14510–e14510.

Gao, Shenghua, Fabao Zhao, Dongwei Kang, et al.. (2023). Discovery of novel sulfonamide substituted indolylarylsulfones as potent HIV-1 inhibitors with better safety profiles. Acta Pharmaceutica Sinica B. 13(6). 2747–2764. 10 indexed citations

Sun, Yanying, Da Feng, Tao Zhang, et al.. (2023). In situ click chemistry-based discovery of 1,2,3-triazole-derived diarylpyrimidines as novel HIV-1 NNRTIs by exploiting the tolerant region I in binding pocket. Bioorganic & Medicinal Chemistry. 96. 117484–117484. 13 indexed citations

Kang, Dongwei, et al.. (2023). In Silico Discovery of Small-Molecule Inhibitors Targeting SARS-CoV-2 Main Protease. Molecules. 28(14). 5320–5320. 6 indexed citations

Sharma, Prem P., Xiangyi Jiang, Brijesh Rathi, et al.. (2022). Design, Synthesis and Structure—Activity Relationships of Phenylalanine-Containing Peptidomimetics as Novel HIV-1 Capsid Binders Based on Ugi Four-Component Reaction. Molecules. 27(18). 5995–5995. 2 indexed citations

Gao, Shenghua, Hongtao Xu, Steven De Jonghe, et al.. (2022). Identification of Polyphenol Derivatives as Novel SARS-CoV-2 and DENV Non-Nucleoside RdRp Inhibitors. Molecules. 28(1). 160–160. 6 indexed citations

10.

Zhang, Tao, Zhongxia Zhou, Dongwei Kang, et al.. (2021). Exploiting the hydrophobic channel of the NNIBP: Discovery of novel diarylpyrimidines as HIV-1 NNRTIs against wild-type and K103N mutant viruses. Bioorganic & Medicinal Chemistry. 42. 116239–116239. 5 indexed citations

11.

Kang, Dongwei, Fenju Wei, Lin Sun, et al.. (2021). Discovery, optimization, and target identification of novel coumarin derivatives as HIV-1 reverse transcriptase-associated ribonuclease H inhibitors. European Journal of Medicinal Chemistry. 225. 113769–113769. 12 indexed citations

12.

Zhao, Tong, Qing Meng, Yanyu Chen, et al.. (2020). Novel Human Urate Transporter 1 Inhibitors as Hypouricemic Drug Candidates with Favorable Druggability. Journal of Medicinal Chemistry. 63(19). 10829–10854. 41 indexed citations

13.

Kang, Dongwei, Da Feng, Yanying Sun, et al.. (2020). Structure-Based Bioisosterism Yields HIV-1 NNRTIs with Improved Drug-Resistance Profiles and Favorable Pharmacokinetic Properties. Journal of Medicinal Chemistry. 63(9). 4837–4848. 59 indexed citations

14.

Kang, Dongwei, Tong Zhao, Zhao Wang, et al.. (2019). Discovery of piperidine-substituted thiazolo[5,4-d]pyrimidine derivatives as potent and orally bioavailable HIV-1 non-nucleoside reverse transcriptase inhibitors. Communications Chemistry. 2(1). 29 indexed citations

15.

Zhou, Zhongxia, Tao Liu, Gaochan Wu, et al.. (2019). Targeting the hydrophobic channel of NNIBP: discovery of novel 1,2,3-triazole-derived diarylpyrimidines as novel HIV-1 NNRTIs with high potency against wild-type and K103N mutant virus. Organic & Biomolecular Chemistry. 17(12). 3202–3217. 43 indexed citations

16.

Kang, Dongwei, Heng Zhang, Zhao Wang, et al.. (2019). Identification of Dihydrofuro[3,4-d]pyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Promising Antiviral Activities and Desirable Physicochemical Properties. Journal of Medicinal Chemistry. 62(3). 1484–1501. 75 indexed citations

17.

Zhan, Peng, Dongwei Kang, & Xinyong Liu. (2019). Resurrecting the Condemned: Identification of N-Benzoxaborole Benzofuran GSK8175 as a Clinical Candidate with Reduced Metabolic Liability. Journal of Medicinal Chemistry. 62(7). 3251–3253. 8 indexed citations

18.

Yang, Yang, Dongwei Kang, Laura A. Nguyen, et al.. (2018). Structural basis for potent and broad inhibition of HIV-1 RT by thiophene[3,2-d]pyrimidine non-nucleoside inhibitors. eLife. 7. 61 indexed citations

19.

Kang, Dongwei, Zhao Wang, Heng Zhang, et al.. (2018). Further Exploring Solvent-Exposed Tolerant Regions of Allosteric Binding Pocket for Novel HIV-1 NNRTIs Discovery. ACS Medicinal Chemistry Letters. 9(4). 370–375. 29 indexed citations

20.

Kang, Dongwei, Yuning Song, Wen‐Ming Chen, Peng Zhan, & Xinyong Liu. (2014). “Old Dogs with New Tricks”: exploiting alternative mechanisms of action and new drug design strategies for clinically validated HIV targets. Molecular BioSystems. 10(8). 1998–2022. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact